Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B F Uretsky

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Circulation|March 1, 1985
Long-term hemodynamic follow-up of cardiac transplant patients treated with cyclosporine and prednisoneM L Greenberg, B F Uretsky, P S Reddy, et al.
Circulation|February 1, 1989
Coronary artery fistula in the heart transplant patient. A potential complication of endomyocardial biopsyJ S Sandhu, B F Uretsky, T R Zerbe, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1986
Human and canine ventricular vasoactive intestinal polypeptide: decrease with heart failureD V Unverferth, T M O'Dorisio, M M Miller, et al.
Circulation|December 11, 1999
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study GroupM Packer, P A Poole-Wilson, P W Armstrong, et al.
Circulation|August 10, 2000
Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trialB F Uretsky, K Thygesen, P W Armstrong, et al.
American Heart Journal|October 1, 1993
Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experienceS Murali, R L Kormos, B F Uretsky, et al.
American Heart Journal|August 1, 1988
Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responsesB F Uretsky, J A Shaver, C S Liang, et al.
The American Journal of Cardiology|March 1, 1989
Hemodynamic effects of lisinopril after long-term administration in congestive heart failureC K Stone, B F Uretsky, T J Linnemeier, et al.
Human Immunology|June 1, 1990
Propagation of infiltrating lymphocytes and graft coronary disease in cardiac transplant recipientsC L Kaufman, A Zeevi, R L Kormos, et al.
Circulation|November 1, 1991
Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter surveyJ D Hosenpud, T DeMarco, O H Frazier, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Circulation|March 1, 1985
Long-term hemodynamic follow-up of cardiac transplant patients treated with cyclosporine and prednisoneM L Greenberg, B F Uretsky, P S Reddy, et al.
Circulation|February 1, 1989
Coronary artery fistula in the heart transplant patient. A potential complication of endomyocardial biopsyJ S Sandhu, B F Uretsky, T R Zerbe, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1986
Human and canine ventricular vasoactive intestinal polypeptide: decrease with heart failureD V Unverferth, T M O'Dorisio, M M Miller, et al.
Circulation|December 11, 1999
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study GroupM Packer, P A Poole-Wilson, P W Armstrong, et al.
Circulation|August 10, 2000
Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trialB F Uretsky, K Thygesen, P W Armstrong, et al.
American Heart Journal|October 1, 1993
Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experienceS Murali, R L Kormos, B F Uretsky, et al.
American Heart Journal|August 1, 1988
Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responsesB F Uretsky, J A Shaver, C S Liang, et al.
The American Journal of Cardiology|March 1, 1989
Hemodynamic effects of lisinopril after long-term administration in congestive heart failureC K Stone, B F Uretsky, T J Linnemeier, et al.
Human Immunology|June 1, 1990
Propagation of infiltrating lymphocytes and graft coronary disease in cardiac transplant recipientsC L Kaufman, A Zeevi, R L Kormos, et al.
Circulation|November 1, 1991
Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter surveyJ D Hosenpud, T DeMarco, O H Frazier, et al.
Pageof 13